Krka group net down 5% in 2015 as sales stagnate

Novo Mesto, 3 March - Drug maker Krka reported a group net profit of just over EUR 158m for 2015, down 5% over the year before. Revenue declined by 2% to EUR 1.16bn, despite an uptick in volume sales, according to unaudited results released on Thursday.